ABELAPHAR · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of ABELAPHAR is 0.8% (low). The 2024 annual accounts show equity of €36k and a net result of €4k. Equity is growing by ~60.2% per year across the filed fiscal years. Its solvency ranks better than 50% of 6698 sector peers (fiscal year 2024). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Signals

2 signals · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Growing equity

Equity grew over 2022-2024. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 13 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-07-2025, 7 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

How we compute the deadline

The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	24-07-2025	7 d early	2025-00302897
31-12-2023	31-07-2024	12-07-2024	19 d early	2024-00255875
31-12-2022	31-07-2023	17-07-2023	14 d early	2023-00258782
31-12-2021	31-07-2022	14-07-2022	17 d early	2022-20213162
31-12-2020	31-07-2021	13-07-2021	18 d early	2021-36000010
31-12-2019	31-07-2020	16-07-2020	15 d early	2020-31500530
31-12-2018	31-07-2019	17-07-2019	14 d early	2019-35300291
31-12-2017	31-07-2018	09-07-2018	22 d early	2018-31600553
31-12-2016	31-07-2017	06-07-2017	25 d early	2017-28800261
31-12-2015	31-07-2016	15-07-2016	16 d early	2016-32600197

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Established

Founded in 2008, 17 years in business.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.8% Low

0%0,5%1,5%4%10%≥25%

Higher-failure-rate sector +Long track record −Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€4k-49.5%

Working capital€41k-20.8%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 24-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~60.2%/year over 7 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	20.1%	20.4%	better than 50% of 6698 sector peers
Net result	€4k	€4k	better than 51% of 6678 sector peers
Equity	€36k	€16k	better than 66% of 6712 sector peers
Gross operating margin	€34k	€24k	better than 57% of 6657 sector peers
Total assets	€181k	€94k	better than 68% of 6702 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P50

Improving position over 2020-2024 · n=1365-6698

Net result P51

Weakening position over 2020-2024 · n=1361-6678

Equity P66

Improving position over 2020-2024 · n=1367-6712

Gross operating margin P57

Stable position over 2020-2024 · n=1356-6657

Describes the position versus peers, not a forecast.

EBITDA

€33k

-17.4% 18-24

Net profit

€4k

-49.5% 18-24

Cash flow

€13k

-28.9% 18-24

Total assets

€181k

+4.3% 18-24

Equity

€36k

+2.6% 18-24

Working capital

€41k

-20.8% 18-24

Income taxes

€3k

-29.6% 18-24

Dividends

€3k

- 18-24

Debt

€145k

+4.8% 18-24

Debt ≤ 1y

€108k

+25.4% 18-24

Debt > 1y

€30k

-35.2% 18-24

Current ratio

1.38

-13.8% 18-24

Quick ratio

0.62

-9.2% 18-24

Solvency

20.1%

-1.7% 18-24

Debt / equity

3.97

+2.1% 18-24

ROE

12.1%

-50.7% 18-24

ROA

2.4%

-51.6% 18-24

Interest coverage

2.00

-16.1% 18-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€33k
Net profit	€4k
Cash flow	€13k
Staff costs	-
Income taxes	€3k
Dividends	€3k
Total assets	€181k
Equity	€36k
Debt	€145k
of which ≤ 1y	€108k
of which > 1y	€30k
Working capital	€41k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	1.38
Quick ratio	0.62
Working capital ratio	22.4%
Solvency	20.1%
Debt / equity	3.97
Long-term debt ratio	0.82
Interest coverage	2.00
Gross margin	-
Net margin	-
ROA	2.4%
ROE	12.1%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €33k · 18.1% Current assets €148k · 81.9%

Equity & liabilities

Equity €36k · 20.1% Debt €145k · 79.9%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€181k
Fixed assets	21/28	€33k
Tangible fixed assets	22/27	€33k
Current assets	29/58	€148k
Stocks & contracts in progress	3	€81k
Amounts receivable within one year	40/41	€57k
Investments	50/53	€5k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€181k
Equity	10/15	€36k
Contributions / capital	10/11	€6k
Reserves	13	€30k
Accumulated profits (losses)	14	€13
Amounts payable	17/49	€145k
Amounts payable after one year	17	€30k
Amounts payable within one year	42/48	€108k
Trade debts payable within one year	44	€43k
Income statement
Gross operating margin	9900	€34k
Operating result	9901	€24k
Financial income	75	€0
Financial charges	65	€17k
Result before taxes	9903	€8k
Income taxes	67/77	€3k
Net result for the period	9904	€4k
Result to be appropriated	9905	€4k

You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

58 / 100 Fair

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

under verification

Directors derived from a single State Gazette act, under verification

All 3 current directors first appear in the same act (23462797). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.

Current directors & mandates

DEPORTE Bart
Director
State Gazette act 23462797 (19-12-2023)

Current
19-12-2023 → present
THIENPONT André Oscar
Director
State Gazette act 23462797 (19-12-2023)

Current
19-12-2023 → present
THIENPONT Ann
Director
State Gazette act 23462797 (19-12-2023)

Current
19-12-2023 → present

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary	Detailhandel in farmaceutische producten(47730)
Legal form	Private limited company(610)
Incorporation	23-12-2008
Status	Active
Postal code	2880

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

1 location

Abelaphar

Karel Van Doorslaerlaan(MAR) 20, 2880 BornemDetailhandel in farmaceutische producten

since 20092.175.353.177

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area567 m²

Buildings1

Building footprint235 m²

Volume (LiDAR)1,772 m³

Tallest building10.6 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
12024A0237/00M002	Flanders	567 m²	1 · 235 m²	10.6 m · 3 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts

All acts · 1 updated 2 years ago

2023

19-12-2023 3 directors appointed Director changes·Ann De Block

THIENPONT Ann, Bestuurder
DEPORTE Bart, Bestuurder
THIENPONT André Oscar, Bestuurder

Notary: Ann De Block · Puurs-Sint-Amands

Original publication ↗

Analysis

Snowflake analysis

financial profile on 5 axes

66 / 100

Strong profile, led by stability.

All 5 axes are computed from data Checked has read.

Health 58

Profitability 60

Solvency 33

Growth 78

Stability 100

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers

Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works